How to buy ImmunoPrecise Antibodies stock (ImmunoPrecise Antibodies)

ImmunoPrecise Antibodies is a biotechnology business based in the US. ImmunoPrecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.40 – a decrease of 0.79% over the previous week. ImmunoPrecise Antibodies employs 72 staff and has a trailing 12-month revenue of around $24.1 million.

Our top picks for where to buy Immunoprecise Antibodies stock

Buy ImmunoPrecise Antibodies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ImmunoPrecise Antibodies stock price (NASDAQ: IPA)

Use our graph to track the performance of IPA stocks over time.

ImmunoPrecise Antibodies shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.40
52-week range	$0.32 - $2.60
50-day moving average more info button	$0.46
200-day moving average more info button	$0.90
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.75

Is it a good time to buy ImmunoPrecise Antibodies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ImmunoPrecise Antibodies price performance over time

Historical closes compared with the close of $0.4001 from 2024-12-20

1 week (2024-12-13)	-0.79%
1 month (2024-11-22)	6.41%
3 months (2024-09-20)	-40.28%
6 months (2024-06-21)	-60.39%

1 year (2023-12-22)	-70.36%
2 years (2022-12-22)	-92.39%
3 years (2021-12-22)	5.49
5 years (2019-12-20)	2

ImmunoPrecise Antibodies financials

Revenue TTM	$24.1 million
Gross profit TTM	$11.6 million
Return on assets TTM	-13.45%
Return on equity TTM	-64.04%
Profit margin	-115.22%
Book value	$1.26
Market Capitalization more info button	$13.4 million

TTM: trailing 12 months

ImmunoPrecise Antibodies share dividends

We're not expecting ImmunoPrecise Antibodies to pay a dividend over the next 12 months.

You may also wish to consider:

• Amgen (AMGN.US) (3.68% forward annual dividend yield)

Have ImmunoPrecise Antibodies's shares ever split?

ImmunoPrecise Antibodies's shares were split on a 1:5 basis on 22 November 2020 . So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ImmunoPrecise Antibodies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for ImmunoPrecise Antibodies shares which in turn could have impacted ImmunoPrecise Antibodies's share price.

ImmunoPrecise Antibodies share price volatility

Over the last 12 months, ImmunoPrecise Antibodies's shares have ranged in value from as little as $0.3248 up to $2.6. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoPrecise Antibodies's is 0.273. This would suggest that ImmunoPrecise Antibodies's shares are less volatile than average (for this exchange).

To put ImmunoPrecise Antibodies's beta into context you can compare it against those of similar companies.

• Amgen (AMGN.US): 0.599
• Regeneron Pharmaceuticals (REGN.US): 0.142
• Biogen (BIIB.US): -0.061

ImmunoPrecise Antibodies overview

ImmunoPrecise Antibodies Ltd. , a biotechnology company, leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform, which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. In addition, it provides phage display, a custom immune library; CAR development, an adaptable antibody, which allows the inclusion of functional data early in the screening funnel; antibody sequencing; and assay development. Further, it offers a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of quality attributes.

Frequently asked questions

null
What percentage of ImmunoPrecise Antibodies is owned by insiders or institutions?
Currently 12.057% of ImmunoPrecise Antibodies shares are held by insiders and 6.58% by institutions. How many people work for ImmunoPrecise Antibodies?
Latest data suggests 72 work at ImmunoPrecise Antibodies. When does the fiscal year end for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies's fiscal year ends in April. Where is ImmunoPrecise Antibodies based?
ImmunoPrecise Antibodies's address is: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8 What is ImmunoPrecise Antibodies's ISIN number?
ImmunoPrecise Antibodies's international securities identification number is: CA45257F2008